Comparison of coronary CT angiography, SPECT, PET, and hybrid imaging for diagnosis of ischemic heart disease determined by fractional flow reserve

JAMA Cardiology

Volumn 2, Issue 10, 2017, Pages 1100-1107

  Danad, Ibrahim ^a   Raijmakers, Pieter G ^a   Driessen, Roel S ^a   Leipsic, Jonathon ^b   Raju, Rekha ^b   Naoum, Chris ^b   Knuuti, Juhani ^c   Mäki, Maija ^c   Underwood, Richard S ^d   Min, James K ^e,f   Elmore, Kimberly ^e,f   Stuijfzand, Wynand J ^a   Van Royen, Niels ^a   Tulevski, Igor I ^g   Somsen, Aernout G ^g   Huisman, Marc C ^a   Van Lingen, Arthur A ^a   Heymans, Martijn W ^a   Van De Ven, Peter M ^a   Van Kuijk, Cornelis ^a   Lammertsma, Adriaan A ^a   Van Rossum, Albert C ^a   Knaapen, Paul ^a   more..

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ST PAUL S HOSPITAL   (Canada)

^c TURKU UNIVERSITY HOSPITAL   (Finland)

^d ROYAL BROMPTON HOSPITAL   (United Kingdom)

^e WEILL CORNELL MEDICAL COLLEGE   (United States)

^f NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^g Cardiology Centers of the Netherlands   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

TETROFOSMIN TC 99M; ORGANOPHOSPHORUS COMPOUND; RADIOPHARMACEUTICAL AGENT; TECHNETIUM COMPLEX; TECHNETIUM TC-99M TETROFOSMIN;

ADULT; ARTICLE; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ANGIOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; FEMALE; FRACTIONAL FLOW RESERVE; HUMAN; HYBRID IMAGING; INTERMETHOD COMPARISON; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NON INVASIVE PROCEDURE; POSITRON EMISSION TOMOGRAPHY; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIATION DOSE; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY; COMPARATIVE STUDY; HEART MUSCLE ISCHEMIA; MULTIMODAL IMAGING; PATHOPHYSIOLOGY; PHYSIOLOGY; STANDARDS;

COMPUTED TOMOGRAPHY ANGIOGRAPHY; CORONARY ANGIOGRAPHY; FEMALE; FRACTIONAL FLOW RESERVE, MYOCARDIAL; HUMANS; MALE; MIDDLE AGED; MULTIMODAL IMAGING; MYOCARDIAL ISCHEMIA; ORGANOPHOSPHORUS COMPOUNDS; ORGANOTECHNETIUM COMPOUNDS; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 85032504761     PISSN: 23806583     EISSN: 23806591     Source Type: Journal    
DOI: 10.1001/jamacardio.2017.2471     Document Type: Article

References (27)

1. Di Carli MF, Hachamovitch R. New technology for noninvasive evaluation of coronary artery disease. Circulation. 2007;115(11):1464-1480.
2. Gaemperli O, Bengel FM, Kaufmann PA. Cardiac hybrid imaging. Eur Heart J. 2011;32(17):2100-2108.
3. Kajander S, Joutsiniemi E, Saraste M, et al. Cardiac positron emission tomography/computed tomography imaging accurately detects anatomically and functionally significant coronary artery disease. Circulation. 2010;122(6):603-613.
4. Danad I, Raijmakers PG, Appelman YE, et al. Hybrid imaging using quantitative H215O PET and CT-based coronary angiography for the detection of coronary artery disease. J Nucl Med. 2013;54(1): 55-63.
5. Tonino PA, De Bruyne B, Pijls NH, et al; FAME Study Investigators. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N Engl J Med. 2009;360(3):213-224.
6. De Bruyne B, Pijls NH, Kalesan B, et al; FAME 2 Trial Investigators. Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease [published correction appears in N Engl J Med. 2012;367(18):1768]. N Engl J Med. 2012;367 (11):991-1001.
7. De Bruyne B, Fearon WF, Pijls NH, et al; FAME 2 Trial Investigators. Fractional flow reserve–guided PCI for stable coronary artery disease. N Engl J Med. 2014;371(13):1208-1217.
8. Cerqueira MD, Weissman NJ, Dilsizian V, et al; American Heart Association Writing Group on Myocardial Segmentation and Registration for Cardiac Imaging. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Int J Cardiovasc Imaging. 2002;18(1):539-542.
9. Danad I, Uusitalo V, Kero T, et al. Quantitative assessment of myocardial perfusion in the detection of significant coronary artery disease: cutoff values and diagnostic accuracy of quantitative [15O]H2O PET imaging. J Am Coll Cardiol. 2014;64(14):1464-1475.
10. Leisenring W, Alonzo T, Pepe MS. Comparisons of predictive values of binary medical diagnostic tests for paired designs. Biometrics. 2000;56(2): 345-351.
11. Montalescot G, Sechtem U, Achenbach S, et al; Task Force Members; ESC Committee for Practice Guidelines; Document Reviewers. 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J. 2013;34(38): 2949-3003.
12. Fihn SD, Blankenship JC, Alexander KP, et al. 2014 ACC/AHA/AATS/PCNA/SCAI/STS focused update of the guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, and the American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation. 2014;130 (19):1749-1767.
13. Tonino PA, Fearon WF, De Bruyne B, et al. Angiographic versus functional severity of coronary artery stenoses in the FAME study: fractional flow reserve versus angiography in multivessel evaluation. J Am Coll Cardiol. 2010;55(25):2816-2821.
14. Abdulla J, Abildstrom SZ, Gotzsche O, Christensen E, Kober L, Torp-Pedersen C. 64-Multislice detector computed tomography coronary angiography as potential alternative to conventional coronary angiography: a systematic review and meta-analysis. Eur Heart J. 2007;28 (24):3042-3050.
15. Neglia D, Rovai D, Caselli C, et al; EVINCI Study Investigators. Detection of significant coronary artery disease by noninvasive anatomical and functional imaging. Circ Cardiovasc Imaging. 2015;8 (3):e002179.
16. Nørgaard BL, Leipsic J, Gaur S, et al; NXT Trial Study Group. Diagnostic performance of noninvasive fractional flow reserve derived from coronary computed tomography angiography in suspected coronary artery disease: the NXT trial (analysis of coronary blood flow using CT angiography: next steps). J Am Coll Cardiol. 2014;63 (12):1145-1155.
17. Min JK, Leipsic J, Pencina MJ, et al. Diagnostic accuracy of fractional flow reserve from anatomic CT angiography. JAMA. 2012;308(12):1237-1245.
18. Mc Ardle BA, Dowsley TF, deKemp RA, Wells GA, Beanlands RS. Does rubidium-82 PET have superior accuracy to SPECT perfusion imaging for the diagnosis of obstructive coronary disease?: a systematic review and meta-analysis. J Am Coll Cardiol. 2012;60(18):1828-1837.
19. Takx RA, Blomberg BA, ElAidi H, etal. Diagnostic accuracyofstressmyocardialperfusionimaging comparedtoinvasivecoronaryangiographywith fractionalflowreservemeta-analysis.CircCardiovasc Imaging.2015;8(1):e002666.
20. Schindler TH, Dilsizian V. PET-determined hyperemic myocardial blood flow: further progress to clinical application. J Am Coll Cardiol. 2014;64 (14):1476-1478.
21. Berman DS, Kang X, Slomka PJ, et al. Underestimation of extent of ischemia by gated SPECT myocardial perfusion imaging in patients with left main coronary artery disease. J Nucl Cardiol. 2007;14(4):521-528.
22. Danad I, Szymonifka J, Twisk JW, et al. Diagnostic performance of cardiac imaging methods to diagnose ischaemia-causing coronary artery disease when directly compared with fractional flow reserve as a reference standard: a meta-analysis. Eur Heart J. 2017;38(13):991-998.
23. Masood Y, Liu YH, Depuey G, et al. Clinical validation of SPECT attenuation correction using x-ray computed tomography–derived attenuation maps: multicenter clinical trial with angiographic correlation. J Nucl Cardiol. 2005;12(6):676-686.
24. Genovesi D, Giorgetti A, Gimelli A, et al. Impact of attenuation correction and gated acquisition in SPECT myocardial perfusion imaging: results of the multicentre SPAG (SPECT Attenuation Correction vs Gated) study. Eur J Nucl Med Mol Imaging. 2011;38 (10):1890-1898.
25. Douglas PS, Hoffmann U, Patel MR, et al; PROMISE Investigators. Outcomes of anatomical versus functional testing for coronary artery disease. N Engl J Med. 2015;372(14):1291-1300.
26. Greenwood JP, Ripley DP, Berry C, et al; CE-MARC 2 Investigators. Effect of care guided by cardiovascular magnetic resonance, myocardial perfusion scintigraphy, or NICE guidelines on subsequent unnecessary angiography rates: the CE-MARC 2 randomized clinical trial. JAMA. 2016; 316(10):1051-1060.
27. Kajander SA, Joutsiniemi E, Saraste M, et al. Clinical value of absolute quantification of myocardial perfusion with 15O-water in coronary artery disease. Circ Cardiovasc Imaging. 2011;4(6): 678-684.